- About Us
- Nano-Social Network
- Nano Consulting
- My Account
September 10th, 2004
Research and Markets has announced the addition of Nanobiotechnology: Opportunities and Technical Analysis to their offering.
Several industries are hindered by the limitations of current technologies. In medicine, clinical diagnostics are often costly and time-consuming. Additionally, most therapeutics lack specificity, and therefore are limited in efficacy and safety. In life science research, the drug discovery process continues to be slowed by existing imaging and screening techniques. Nanobiotechnology promises to provide novel tools and materials that address current technological limitations, and thereby holds great promise for significant advances in both medicine and life science research.
|Related News Press|
New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017